/ CompletedNot Applicable 硫酸氢氯吡格雷片(75mg)在健康受试者中的餐后的生物等效性试验
[Translation] Postprandial bioequivalence study of clopidogrel bisulfate tablets (75 mg) in healthy subjects
以西班牙莱斯维制药公司生产的硫酸氢氯吡格雷片(75mg)为受试制剂,以法国Sanofi Winthrop Industrie生产、赛诺菲(杭州)制药有限公司分装的硫酸氢氯吡格雷片(75mg,波立维)为参比制剂,评估健康受试者在餐后状态下单次口服受试制剂和参比制剂的相对生物利用度,评价两制剂的生物等效性。
[Translation] Using clopidogrel bisulfate tablets (75 mg) produced by Spain's Lesvi Pharmaceuticals as the test preparation, and clopidogrel bisulfate tablets (75 mg, Plavix) produced by France's Sanofi Winthrop Industrie and packaged by Sanofi (Hangzhou) Pharmaceutical Co., Ltd. as the reference preparation, the relative bioavailability of the test preparation and the reference preparation after a single oral administration in healthy subjects in the postprandial state was evaluated, and the bioequivalence of the two preparations was evaluated.
/ CompletedNot Applicable 硫酸氢氯吡格雷片(75mg)在健康受试者中的空腹/餐后的生物等效性试验
[Translation] Fasting/fed bioequivalence study of clopidogrel bisulfate tablets (75 mg) in healthy subjects
以西班牙莱斯维制药公司生产的硫酸氢氯吡格雷片(75mg)为受试制剂,以法国Sanofi Winthrop Industrie生产、赛诺菲(杭州)制药有限公司分装的硫酸氢氯吡格雷片(75mg,波立维®)为参比制剂,评估健康受试者分别在空腹和餐后状态下单次口服受试制剂和参比制剂的相对生物利用度,评价两制剂的生物等效性。
[Translation] Using clopidogrel bisulfate tablets (75 mg) produced by Spanish pharmaceutical company Lesvi as the test preparation, and clopidogrel bisulfate tablets (75 mg, Plavix®) produced by French Sanofi Winthrop Industrie and packaged by Sanofi (Hangzhou) Pharmaceutical Co., Ltd. as the reference preparation, the relative bioavailability of the test preparation and the reference preparation after a single oral administration in healthy subjects in the fasting and postprandial states was evaluated, and the bioequivalence of the two preparations was evaluated.
100 Clinical Results associated with Esseti Farmaceutici Srl
0 Patents (Medical) associated with Esseti Farmaceutici Srl
100 Deals associated with Esseti Farmaceutici Srl
100 Translational Medicine associated with Esseti Farmaceutici Srl